A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
Refeyn Ltd.
Unit 9, Trade City, Sandy Ln W, Oxford OX4 6FF, United Kingdom
Phone: +44 1865 800175
Refeyn Headquarters
21 Hickory Drive, Ste. 200A,
Waltham MA 02451
USA
Phone: + 1 (971) 200 1370
© 2025 Refeyn Ltd. All Rights Reserved.
